{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:43:27Z","timestamp":1788219807449,"version":"build-2803163510"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Visceral l eishmaniasis (VL), also known as kala-azar, had once been targeted for elimination in 2020, which now has been shifted to 2030. The year 2020 was also the year in which the world was gripped by the coronavirus disease 2019 (COVID-19) pandemic. This review sheds light on the impact of COVID-19 on VL elimination programmes and the increasing incidences of COVID-19\/VL cases. Lockdowns were imposed worldwide that led to the suspension of surveys, active case finding and mass drug administration, which are important activities to manage neglected tropical diseases. Healthcare machinery was redirected to control the pandemic and acute resource shortages were seen. Budget cuts from funding agencies and donors also came as a severe blow. Priority changes for manufacturers of drugs and diagnostic kits have also exacerbated the situation. Cases where patients were co-infected with VL and COVID-19 were reported across various settings and in people of various age groups, posing unprecedented challenges in diagnosis and treatment. Concerted efforts from all stakeholders are required to understand and deal with the impact that this pandemic has had on VL.<\/jats:p>","DOI":"10.1093\/trstmh\/trac100","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T21:38:12Z","timestamp":1666733892000},"page":"67-71","source":"Crossref","is-referenced-by-count":17,"title":["Visceral leishmaniasis in the COVID-19 pandemic era"],"prefix":"10.1093","volume":"117","author":[{"given":"Anindita","family":"Paul","sequence":"first","affiliation":[{"name":"Department of Biotechnology, National Institute of Pharmaceutical Education and Research , SAS Nagar, Mohali, Punjab-160062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushma","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, National Institute of Pharmaceutical Education and Research , SAS Nagar, Mohali, Punjab-160062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,10,25]]},"reference":[{"issue":"8","key":"2023020109504857100_bib1","doi-asserted-by":"crossref","first-page":"e006835","DOI":"10.1136\/bmjgh-2021-006835","article-title":"Control of visceral leishmaniasis in East Africa: fragile progress, new threats","volume":"6","author":"Dahl","year":"2021","journal-title":"BMJ Glob Health"},{"key":"2023020109504857100_bib2","volume-title":"Fifteenth Meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases, 7\u20138 February 2022","author":"World Health Organization","year":"2022"},{"issue":"5","key":"2023020109504857100_bib3","doi-asserted-by":"crossref","first-page":"e0009373","DOI":"10.1371\/journal.pntd.0009373","article-title":"New global targets for NTDs in the WHO roadmap 2021\u20132030","volume":"15","author":"Casulli","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"(39):","key":"2023020109504857100_bib4","first-page":"461","article-title":"Neglected tropical diseases: impact of COVID-19 and WHO's response","volume":"95","author":"World Health Organization","year":"2020","journal-title":"Wkly Epidemiol Rec"},{"key":"2023020109504857100_bib5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijid.2021.10.003","article-title":"COVID-19 pandemic causes increased clinic visits with diagnosis of tegumentary leishmaniasis in Brazil in 2020","volume":"113","author":"Andrade","year":"2021","journal-title":"Int J Infect Dis"},{"key":"2023020109504857100_bib6","first-page":"430","article-title":"COVID-19 in a patient with visceral leishmaniasis","volume":"8","author":"Miotti","year":"2020","journal-title":"J Infect Dis Ther"},{"key":"2023020109504857100_bib7","first-page":"6629966","article-title":"Clinical misdiagnosis of COVID-19 infection with confusing clinical course","volume-title":"Case Rep Infect Dis.","author":"Eshaghi","year":"2021"},{"issue":"2","key":"2023020109504857100_bib8","first-page":"1","article-title":"Visceral leishmaniasis in an Ethiopian patient with COVID-19: a case report","volume":"7","author":"Amogne","year":"2022","journal-title":"J Clin Med Case Stud."},{"key":"2023020109504857100_bib9","doi-asserted-by":"crossref","first-page":"e01358","DOI":"10.1016\/j.idcr.2021.e01358","article-title":"Visceral leishmaniasis and COVID-19 coinfection \u2013 a case report","volume":"27","author":"Pikoulas","year":"2021","journal-title":"IDCases"},{"issue":"3","key":"2023020109504857100_bib10","first-page":"40","article-title":"A rare case of visceral leishmaniasis and COVID-19 co-infection. Misdiagnosis in the COVID era","volume":"15","author":"Iuliano","year":"2021","journal-title":"Ital J Med"},{"key":"2023020109504857100_bib11","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1590\/s1678-9946202264021","article-title":"Severe visceral leishmaniasis and COVID-19 coinfection in an immunosuppressed patient","volume":"64","author":"Martins","year":"2022","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"2023020109504857100_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13071-016-1292-0","article-title":"Feasibility of eliminating visceral leishmaniasis from the Indian subcontinent: explorations with a set of deterministic age-structured transmission models","volume":"9","author":"Le Rutte","year":"2016","journal-title":"Parasit Vectors"},{"key":"2023020109504857100_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.epidem.2017.01.002","article-title":"Elimination of visceral leishmaniasis in the Indian subcontinent: a comparison of predictions from three transmission models","volume":"18","author":"Le Rutte","year":"2017","journal-title":"Epidemics"},{"issue":"Suppl 4","key":"2023020109504857100_bib14","doi-asserted-by":"crossref","first-page":"S301","DOI":"10.1093\/cid\/ciy007","article-title":"Policy recommendations from transmission modeling for the elimination of visceral leishmaniasis in the Indian subcontinent","volume":"66","author":"Le Rutte","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2023020109504857100_bib15","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.pt.2019.06.007","article-title":"Post-kala-azar dermal leishmaniasis as a reservoir for visceral leishmaniasis transmission","volume":"35","author":"Le Rutte","year":"2019","journal-title":"Trends Parasitol"},{"key":"2023020109504857100_bib16","first-page":"1","article-title":"The potential impact of programmes interruptions due to COVID-19 on 7 neglected tropical diseases: a modelling-based analysis","volume":"4","author":"NTD Modelling Consortium","year":"2020","journal-title":"Gates Open Res"},{"issue":"10","key":"2023020109504857100_bib17","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/trstmh\/traa072","article-title":"Neglecting the effect of COVID-19 on neglected tropical diseases: the Ethiopian perspective","volume":"114","author":"Abdela","year":"2020","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2023020109504857100_bib18","volume-title":"COVID-19: operational guidance for maintaining essential health services during an outbreak: interim guidance, 25 March 2020","author":"World Health Organization","year":"2020"},{"issue":"3","key":"2023020109504857100_bib19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/trstmh\/trab012","article-title":"Modelling the impact of COVID-19-related programme interruptions on visceral leishmaniasis in India","volume":"115","author":"Le Rutte","year":"2021","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2023020109504857100_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12879-019-4719-3","article-title":"Intensely clustered outbreak of visceral leishmaniasis (kala-azar) in a setting of seasonal migration in a village of Bihar, India","volume":"20","author":"Kumar","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"8","key":"2023020109504857100_bib21","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/cid\/ciaa933","article-title":"Predicted impact of COVID-19 on neglected tropical disease programs and the opportunity for innovation","volume":"72","author":"Toor","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2023020109504857100_bib22","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.pt.2021.05.003","article-title":"The impact of COVID-19 on neglected parasitic diseases: what to expect?","volume":"37","author":"Miguel","year":"2021","journal-title":"Trends Parasitol"},{"key":"2023020109504857100_bib23","volume-title":"Impact of the COVID-19 pandemic on seven neglected tropical diseases: a model-based analysis","author":"World Health Organization","year":"2021"},{"issue":"1","key":"2023020109504857100_bib24","doi-asserted-by":"crossref","first-page":"taaa179","DOI":"10.1093\/jtm\/taaa179","article-title":"Neglected tropical diseases in non-endemic countries in the era of COVID-19 pandemic: the great forgotten","volume":"28","author":"Tilli","year":"2021","journal-title":"J Travel Med"},{"issue":"10286","key":"2023020109504857100_bib25","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(21)00786-8","article-title":"What the ODA cuts mean for us","volume":"397","author":"Richter","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"2023020109504857100_bib26","doi-asserted-by":"crossref","first-page":"e574","DOI":"10.1016\/S2666-5247(21)00285-8","article-title":"New threats to visceral leishmaniasis control","volume":"2","author":"Makoni","year":"2021","journal-title":"Lancet Microbe"},{"key":"2023020109504857100_bib27","volume-title":"Call for evidence on impact of UK aid cuts: M\u00e9decins Sans Fronti\u00e8res\/Doctors Without Borders submission to International Development Committee","author":"M\u00e9decins Sans Fronti\u00e8res","year":"2021"},{"issue":"2","key":"2023020109504857100_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/trstmh\/traa118","article-title":"Diagnostics and the neglected tropical diseases roadmap: setting the agenda for 2030","volume":"115","author":"Souza","year":"2021","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2023020109504857100_bib29","volume-title":"Liposomal amphotericin B: solving the access puzzle. M\u00e9decins Sans Fronti\u00e8res Access Campaign","author":"M\u00e9decins Sans Fronti\u00e8res","year":"2022"},{"issue":"11","key":"2023020109504857100_bib30","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"2023020109504857100_bib31","doi-asserted-by":"crossref","first-page":"110289","DOI":"10.1016\/j.mehy.2020.110289","article-title":"Should an intersection between visceral leishmaniasis endemicity and the COVID-19 pandemic be considered?","volume":"144","author":"Carvalho","year":"2020","journal-title":"Med Hypotheses"},{"issue":"3","key":"2023020109504857100_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/trstmh\/trab023","article-title":"Evaluating the potential impact of interruptions to neglected tropical disease programmes due to COVID-19","volume":"115","author":"Hollingsworth","year":"2021","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2023020109504857100_bib33","volume-title":"Process of validation of elimination of kala-azar as a public health problem in South-East Asia","author":"World Health Organization","year":"2016"},{"key":"2023020109504857100_bib34","volume-title":"Regional strategic framework for elimination of kala-azar from the South-East Asia Region (2011\u20132015)","author":"World Health Organization Regional Office for South-East Asia","year":"2012"},{"issue":"(26)","key":"2023020109504857100_bib35","first-page":"297","article-title":"Kala-azar in India \u2013 progress and challenges towards its elimination as a public health problem","volume":"96","author":"World Health Organization","year":"2021","journal-title":"Wkly Epidemiol Rec"}],"container-title":["Transactions of The Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/117\/2\/67\/49016929\/trac100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/117\/2\/67\/49016929\/trac100.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T21:14:46Z","timestamp":1675286086000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article\/117\/2\/67\/6773086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,10,25]]},"published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/trstmh\/trac100","relation":{},"ISSN":["0035-9203","1878-3503"],"issn-type":[{"value":"0035-9203","type":"print"},{"value":"1878-3503","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2]]},"published":{"date-parts":[[2022,10,25]]}}}